What's Happening?
A new study by Gateway Health Alliances (GHA) has demonstrated that two botanical extracts, Dyglomera and CQR-300, can enhance the activity of the satiety hormone GLP-1. Conducted over 16 weeks with 248
overweight and obese adults, the study found that these extracts significantly increased GLP-1 levels and reduced DPP-4 activity, an enzyme that degrades GLP-1. The findings suggest that these botanicals could offer a natural alternative to GLP-1 receptor agonist drugs, which are used for weight management but may not be accessible or tolerable for everyone.
Why It's Important?
The study highlights the potential of botanical extracts as a natural solution for weight management, offering an alternative to pharmaceutical interventions like semaglutide. This could be particularly beneficial for individuals who cannot afford or tolerate such medications. The research may lead to increased interest in plant-based supplements for metabolic health, potentially expanding the market for natural health products. It also underscores the importance of exploring diverse approaches to weight management, which could lead to more personalized and accessible treatment options.
Beyond the Headlines
The focus on botanical extracts reflects a broader trend towards natural and holistic health solutions. As consumers become more health-conscious and seek alternatives to pharmaceuticals, the demand for plant-based supplements is likely to grow. This trend may also drive further research into the efficacy and safety of botanicals, contributing to a more comprehensive understanding of their role in health and wellness.
